The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Open accessAbstract
Cancer incidence is rising and this global challenge is further exacerbated by tumour resistance to available medicines. A promising approach to meet the need for improved cancer treatment is drug repurposing. Here we highlight the potential for repurposing disulfiram (also known by the trade name Antabuse), an old alcohol-aversion drug that has been shown to be effective against diverse cancer types in preclinical studies. Our nationwide epidemiological study reveals that patients who continuously used disulfiram have a lower risk of death from cancer compared to those who stopped using the drug at their diagnosis. Moreover, we identify the ditiocarb-copper complex as the metabolite of disulfiram that is responsible for its anti-cancer effects, and provide methods to detect preferential accumulation of the complex in tumours and candidate biomarkers to analyse its effect on cells and tissues. Finally, our functional and biophysical analyses reveal the molecular target of disulfiram's tumour-suppressing effects as NPL4, an adaptor of p97 (also known as VCP) segregase, which is essential for the turnover of proteins involved in multiple regulatory and stress-response pathways in cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DIS`s definitive antineoplastic mechanism of action, identified over the past decade, involves the molecular target NPL4, which is an adapter for the p97/VCP segregase and is essential for protein turnover, playing a role in several regulatory and stress-responsive cellular pathways.26”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a nationwide epidemiological study revealed that patients who continuously used DIS have a lower risk of death from cancer compared to those who stopped using the drug at their diagnosis.26”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“This triggers a multifaceted cellular stress response culminating in cell death,26”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“Intracellular Cu(DDC)2 binds NPL4, inducing aggregation that disrupts the essential p97-NPL4-UFD1 segregase pathway.”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“DIS’s cytotoxic activity stems from its rapid metabolism to Cu(DDC)2, which preferentially accumulates in tumors.”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“This initial observation has since been substantiated through extensive research, including analyses of Danish demographic and health registries that observed lower mortality rates for colon, prostate, and breast cancers among ongoing DSF users compared to former users.111”
From Drug repurposing for cancer therapy (2024) · cites this paper as [111]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Molecular Chaperone Functions in Protein Folding and Proteostasis
Kim, Y., Hipp, M. S., Bracher, A., Hayer-Hartl, M. K., & Hartl, F. U. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060208-092442 · Cited by 1,545
Target identification using drug affinity responsive target stability (DARTS)
Lomenick, B., Hao, R., Jonai, N., Chin, R., Aghajan, M., Warburton, S., Wang, J., Wu, R. P., Gómez, F., Loo, J. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910040106 · Cited by 1,130
Thygesen, L. C., Daasnes, C., Thaulow, I., & Brønnum‐Hansen, H. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811399956 · Cited by 1,089
Role of Rpn11 Metalloprotease in Deubiquitination and Degradation by the 26 S Proteasome
Verma, R., Aravind, L., Oania, R. S., McDonald, W. H., Yates, J. R., Koonin, E. V., & Deshaies, R. J. (2002) · Science · doi:10.1126/science.1075898 · Cited by 994
Self-citationDoil, C., Mailand, N., Bekker‐Jensen, S., Ménard, P., Larsen, D. H., Pepperkok, R., Ellenberg, J., Panier, S., Durocher, D., Bártek, J., et al. (2009) · Cell · doi:10.1016/j.cell.2008.12.041 · Cited by 982
Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system
Meyer, H. H., Bug, M., & Bremer, S. (2012) · Nature Cell Biology · doi:10.1038/ncb2407 · Cited by 832
Chen, D., Cui, Q. C., Yang, H., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2126 · Cited by 683
Self-citationCell death assays for drug discovery
Kepp, O., Galluzzi, L., Lipinski, M. M., Yuan, J., & Kroemer, G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3373 · Cited by 587
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Becker, L. A., Huang, B., Bieri, G., Ma, R., Knowles, D. A., Jafar-Nejad, P., Messing, J., Kim, H. J., Soriano, A., Auburger, G., et al. (2017) · Nature · doi:10.1038/nature22038 · Cited by 571
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 812
Loaiza, S., Ferreira, S. A., Chinn, T. M., Kirby, A. C., Tsolaki, E., Dondi, C., Parzych, K., Strange, A. P., Bozec, L., Bertazzo, S., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.08.041 · Cited by 10
Paun, R. A., Dumut, D. C., Li, L., Radzioch, D., & Tabrizian, M. (2025) · npj Biomedical Innovations. · doi:10.1038/s44385-024-00006-6 · Cited by 9
Cuproptosis-related genes and agents: implications in tumor drug resistance and future perspectives
Xu, L., Cao, X., Deng, Y., Zhang, B., Li, X., Liu, W., Ren, W., Tang, X., Kong, X., & Zhang, D. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1559236 · Cited by 9
Dang, M., Li, Q., Shi, X., He, A., Li, X., Dai, Z., Rui, J., Ning, W., Teng, Z., Dong, H., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.164958 · Cited by 9
Li, A., Xu, S., Fan, J., Liu, J., Song, X., Cao, L., Gong, Z., & Lu, X. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102537 · Cited by 9
Unraveling the regulatory role of endoplasmic-reticulum-associated degradation in tumor immunity
Qin, X., Denton, W. D., Huiting, L. N., Smith, K. S., & Feng, H. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1784085 · Cited by 9
Ribosomopathies and cancer: pharmacological implications
Temaj, G., Saha, S., Dragusha, S., Ejupi, V., Buttari, B., Profumo, E., Beqa, L., & Saso, L. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2098110 · Cited by 9
Beaudry, A., Jacques-Ricard, S., Darracq, A., Sgarioto, N., Garcia, A., García, T. R., Lemieux, W., Béland, K., Haddad, E., Cordeiro, P., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-43219-2 · Cited by 9
Guo, J., Ma, Y., Tang, T., Bian, Z., Li, Q., Tang, L., Li, Z., Li, M., Wang, L., Zeng, A., et al. (2024) · Journal of Cancer · doi:10.7150/jca.89120 · Cited by 9
Fawal, G. F. E., & Abu-Serie, M. M. (2024) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-024-00527-w · Cited by 9
The promising antitumour drug disulfiram inhibits viability and induces apoptosis in cardiomyocytes
Li, Y., Shen, J., Fang, M., Huang, X. B., Yan, H., Jin, Y., Li, J., & Li, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.123 · Cited by 9
Self-citationDrug Repurposing in Oncology, an Attractive Opportunity for Novel Combinatorial Regimens
Falvo, P., Orecchioni, S., Roma, S., Raveane, A., & Bertolini, F. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327999200817104912 · Cited by 9
Huang, W., Zhang, J., Liu, S., Hu, C., Zhang, M., Cheng, S., Yu, H., Zheng, M., Wu, J., Lu, Y., et al. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s342641 · Cited by 9
Carvalho, D. M., Temelso, S., Mackay, A. G., Pemberton, H. N., Rogers, R. F., Kessler, K., Izquierdo, E., Bjerke, L. M., Salom, J. F., Clarke, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.29.424674 · Cited by 10
Identification of novel dithiocarbamate-copper complexes targeting p97/NPL4 pathway in cancer cells
Löffelmann, M., Škrott, Z., Majera, D., Štarha, P., Kryštof, V., & Mistrík, M. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115790 · Cited by 8
Self-citationDing, Y., Huang, Z., Luo, Y., Lin, H., Wang, J., Zeng, Z., Zhang, T., Chen, Y., Gong, Y., Zhang, M., et al. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.08.009 · Cited by 8
Villegas‐Vázquez, E. Y., Marín-Carrasco, F. P., Reyes‐Hernández, O. D., Báez-González, A. S., Bustamante-Montes, L. P., Padilla‐Benavides, T., Granados, L. I. Q., & Figueroa‐González, G. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2024.1514120 · Cited by 8
Jiang, C., Xin, H., Liu, Y., & Han, Y. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1566986 · Cited by 9
DDTC-Cu(I) Nano-MOF Induces Ferroptosis by Targeting SLC7A11/GPX4 Signal in Colorectal Cancer
Huang, J., Yang, M., Zhou, X., Luo, J., Yan, X., Lin, G., Li, S., Liu, S., Song, Z., Tang, C., et al. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00680 · Cited by 8
Dong, A., Wei, G., Liang, Z., Di, Y., Tang, Y., Ling, Y., Li, S., Chen, Y., Zhou, Y., Wang, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61397-7 · Cited by 8
Yu, F., Li, S., Li, B., Zhan, P., Wang, X., & Yang, J. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118325 · Cited by 9
The Tao of Copper Metabolism: From Physiology to Pathology
Gao, S., Zhou, M., & Tang, Z. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230915162405 · Cited by 8
Meng, X., Wu, J., Hu, Z., & Zheng, X. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02491a · Cited by 8
Huang, Y., Chen, J., Hsiung, C., Bai, Y., Tan, Z., Ye, S., & Zhang, X. (2024) · Molecular Biology of the Cell · doi:10.1091/mbc.e23-11-0442 · Cited by 8
Liu, J., Tagami, T., Ogawa, K., & Ozeki, T. (2024) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b23-00789 · Cited by 8
Zhao, D., Zhou, A., Dong, X., Meng, H., He, Y., Qu, L., Zhang, K., Lin, Y., & Li, Z. (2024) · Theranostics · doi:10.7150/thno.96136 · Cited by 8
Khan, H. J., Rohondia, S. O., Ahmed, Z. S. O., Zalavadiya, N., & Dou, Q. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819668-7.00005-1 · Cited by 8
Self-citationMistrík, M., Škrott, Z., Müller, P., Panáček, A., Hochvaldová, L., Chromá, K., Buchtová, T., Vandová, V., Kvítek, L., & Bártek, J. (2021) · Nature Communications · doi:10.1038/s41467-021-20989-9 · Cited by 9
Bioengineering extracellular vesicles as novel nanocarriers towards brain disorders
Wu, J., Ma, L., Sun, D., Zhang, X., Cui, J., Du, Y., Guo, Y., Wang, X., Di, L., & Wang, R. (2022) · Nano Research · doi:10.1007/s12274-022-4913-2 · Cited by 8
Liu, H., Kong, Y., Liang, X., Liu, Z., Guo, X., Yang, B., Yin, T., He, H., Gou, J., Zhang, Y. X., et al. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2155631 · Cited by 8
Su, M., Tian, H., Zhou, L., Li, Q., Wang, S., Haung, C., Nice, E. C., Zheng, S., & Li, J. (2023) · Materials & Design · doi:10.1016/j.matdes.2023.111613 · Cited by 8
Self-citationXiao, P., Tao, X., Wang, H., Liu, H., Feng, Y., Zhu, Y., Jiang, Z., Yin, T., Zhang, Y. X., He, H., et al. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2237888 · Cited by 8
Hu, J., Tian, J., Wang, K., Deng, J., & Luo, G. (2019) · Journal of Flow Chemistry · doi:10.1007/s41981-019-00046-9 · Cited by 8
Bakthavatsalam, S., Sleeper, M. L., Dharani, A. M., George, D. J., Zhang, T., & Franz, K. J. (2018) · Angewandte Chemie · doi:10.1002/ange.201807582 · Cited by 8
Nuclear bodies protect phase separated proteins from degradation in stressed proteomePreprint
Jung, K. H., Sun, J., Hsiung, C., Lian, X. L., Liu, Y., & Zhang, X. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.19.537522 · Cited by 8
Released dsDNA‐triggered inflammasomes serve as intestinal radioprotective targets
Chen, L., Wang, Z., Wu, J., Yao, Q., Peng, J., Zhang, C., Chen, H., Li, Y., Jiang, Z., Liu, Y., et al. (2023) · Clinical & Translational Immunology · doi:10.1002/cti2.1452 · Cited by 7
Safari, M. H., Rahimzadeh, P., Alaei, E., Alimohammadi, M., Esfandiari, N., Daneshi, S., Malgard, N., Farahani, N., Taheriazam, A., & Hashemi, M. (2025) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2025.102013 · Cited by 8
Disulfiram inhibits bacterial growth by inducing zinc-dependent reactive oxygen species
Luo, Q., Wu, Z., Pan, Y., & Zhang, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1619416 · Cited by 7
Bai, G., Liu, H., Li, W., Chen, S., Wang, L., Wang, Z., Zhou, Y., Pan, Y., Liu, Y., Chen, Q., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03689-0 · Cited by 8
Roles and mechanisms of cuproptosis for reversing cancer therapeutic resistance
Wu, T., Wang, S., Liu, Y., Bai, X., & Chen, S. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126267 · Cited by 7
Cuproptosis and its cooperative role in cancer therapy: exploring new treatment strategies
Xu, Q., Lai, Q., Wang, J., Feng, S., Gu, W., Song, L., Wang, S., Xiao, Y., & Zhao, Q. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217519 · Cited by 7
Metabolic underpinnings of cuproptosis
Jiang, D., Zhuang, L., Koong, A. C., & Gan, B. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.04.009 · Cited by 7
Carraro, U., Bittmann, F. N., Ivanova, E. P., Jónsson, H., Kern, H., Leeuwenburgh, C., Mayr, W., Scalabrin, M., Schaefer, L. V., Smeriglio, P., et al. (2022) · European Journal of Translational Myology · doi:10.4081/ejtm.2022.10521 · Cited by 7
Knowledge mapping of copper-induced cell death: A bibliometric study from 2012 to 2022
Ren, X., Pan, C., Pan, Z., Zhao, S., Wu, C., Chen, W., Liu, M., Han, X., Kuang, H., & Qu, M. (2022) · Medicine · doi:10.1097/md.0000000000031133 · Cited by 7
Huang, D., Yao, Y., Lou, Y., Kou, L., Yao, Q., & Chen, R. (2024) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2024.100307 · Cited by 7
Butcher, K., Wang, Z., Kurusamy, S., Zhang, Z., Morris, M. R., Najlah, M., McConville, C., Kannappan, V., & Wang, W. (2024) · Biomolecules · doi:10.3390/biom14121651 · Cited by 7
Liu, L., Shao, M., Guo, L., Wang, W., Zheng, X., & Jiang, X. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.4c06487 · Cited by 7
Discovery of novel pyrimidine molecules containing boronic acid as VCP/p97 Inhibitors
Zhang, Y., Xie, X., Wang, X., Wen, T., Zhao, C., Liu, H., Zhao, B., & Zhu, Y. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116114 · Cited by 7
Zhang, H., Tang, W., Gong, Q., Yang, X., Sun, Y., Dai, Z., Hu, Z., & Zheng, X. (2022) · Nanoscale · doi:10.1039/d2nr03676b · Cited by 7
Chen, X., Chen, W., Xu, H., Tian, Y., Wang, X., Chen, X., Li, J., Luo, S., & Hao, L. (2024) · Aesthetic Surgery Journal · doi:10.1093/asj/sjae075 · Cited by 8
Self-citationDrinking in despair: Unintended consequences of automation in China
Lu, W., & Fan, S. (2024) · Health Economics · doi:10.1002/hec.4865 · Cited by 7
Luo, Q., Shi, W., Wang, P., Zhang, Y. X., Meng, J., & Zhang, L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060895 · Cited by 7
Yoon, S., & Kim, H. S. (2021) · In Vivo · doi:10.21873/invivo.12599 · Cited by 7
A Chemical Screen Identifies a Link between Lipid Metabolism and mRNA Translation
Corman, A., Kanellis, D. C., Michalska, P., Häggblad, M., Lafarga, V., Bártek, J., Puigvert, J. C., & Fernández-Capetillo, Ó. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3001263 · Cited by 7
Jack of all trades inhibits inflammation (in sober people)
Schmidt, F. I., & Latz, E. (2020) · Nature Immunology · doi:10.1038/s41590-020-0693-6 · Cited by 7
Shao, X., Xing, F., Zhang, Y., Lok, C., & Che, C. (2024) · Chemical Science · doi:10.1039/d3sc04834a · Cited by 6
Targeting cuproptosis for cancer therapy: Focus on the anti-tumor immune system
Zhang, X., & Han, X. (2024) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.07.005 · Cited by 6
Xu, H., Bai, L., Yang, J., Yang, W., & Hu, Y. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.126513 · Cited by 6
Zhao, G., Guo, F., Yan, W., Qu, Y., Yan, C., Lv, H., Li, G., Zhao, J., Xie, H., Li, Y., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101882 · Cited by 6
Aldehyde metabolism governs resilience of mucociliary clearance to air pollution exposure
Shinjyo, N., Kimura, H., Yoshihara, T., Suzuki, J., Yamaguchi, M., Kawabata, S., & Okabe, Y. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191276 · Cited by 6
Liposomal delivery of a disulfiram metabolite drives copper-mediated tumor immunity
Heroux, D., Leung, A. W. Y., Gilabert‐Oriol, R., Kulkarni, J. A., Anantha, M., Cullis, P. R., & Bally, M. B. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126010 · Cited by 10
Copper Homeostasis, Emerging Central Players in Cancer Immunotherapy
Chen, C., Peng, M., Liang, S., Li, C., Zhu, L., Yang, Y., Li, L., & Xue, W. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70611 · Cited by 6
Meng, Y., Zhuang, Y., Yuan, B., Lv, B., Zhang, L., Zhang, W., Qu, X., Chen, Y., & Tang, B. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217361 · Cited by 6
The molecular mechanism of cuproptosis and research progress in pancreatic diseases
Wang, Q., Chen, H., Lv, Z., Zhang, P., Li, Y., Zhao, C., & Li, S. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2608490 · Cited by 7
Tang, H., Zhang, J.-T., Liu, C., Wang, S., Zheng, X., & Chen, A. (2023) · Journal of CO2 Utilization · doi:10.1016/j.jcou.2023.102426 · Cited by 6
Hu, X., Wang, M., Shi, S., Raja, M. R. K., Gupta, G., Chen, H., & Xu, P. (2023) · Biomaterials Science · doi:10.1039/d3bm00627a · Cited by 6
Wang, H., Liang, L., Xie, Y., Gong, H., Fan, F., Wen, C., Yu, J., Lei, S., Qiu, X., Peng, H., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03245-4 · Cited by 6
Wu, S., Weng, J., Pan, Y., Wen, Z., Zeng, J., Lou, Y., Tong, S., Liao, P., Li, N., Yu, Z., et al. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111563 · Cited by 6
Feng, Y., Chen, H., Chen, S., Zhang, K., Yun, D., Liu, D., Zeng, J., Yang, C., & Xie, Q. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125293 · Cited by 6
Possible Therapeutic Potential of Disulfiram for Multiple Myeloma
Drozdková, D. W., & Trtková, K. S. (2021) · Current Oncology · doi:10.3390/curroncol28030193 · Cited by 6
Li, Z., Xie, X., Tan, G., Xie, F., Liu, N., Li, W., & Sun, X. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b21-00353 · Cited by 6
Zhang, W., Zhai, Q., Li, M., Huang, S., Sun, Z., Yan, Z., Li, J., Li, L., & Li, Y. (2022) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-022-05447-w · Cited by 6
Self-citationThe p53 Tumor Suppressor and Copper Metabolism: An Unrevealed but Important Link
Tsymbal, S. A., Refeld, A. G., & Kuchur, О. А. (2022) · Molecular Biology · doi:10.1134/s0026893322060188 · Cited by 6
Zheng, Y., Wei, K., Gao, Y., Zhou, Z., Zheng, X., Li, J., & Qi, J. (2022) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2022.112116 · Cited by 6
Self-citationScrima, S., Tiberti, M., Ryde, U., Lambrughi, M., & Papaleo, E. (2023) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2023.140921 · Cited by 6
Zhou, M., Tian, B., Bu, Y., Wu, Z., Yu, J., Wang, S., Sun, X., Zhu, X., & Zhou, H. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00323 · Cited by 6
Banerjee, J., Tiwari, A. K., & Banerjee, S. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.03.032 · Cited by 6
Sui, X., Pan, M., & Li, Y. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191004162411 · Cited by 6
Pang, L., Zhong, W. H., Wang, Q., Feng, H., Dong, H., Wang, S., Cong, H., Shen, Y., & Yu, B. (2021) · Science China Technological Sciences · doi:10.1007/s11431-021-1841-y · Cited by 6
Copper (α)/ cis -platinum-loaded nanogels as an adjuvant potentiate disulfiram's antitumor efficacy
Geng, Y., Sun, R., Zhang, Y., Zhou, Z., & Shen, Y. (2022) · Biomaterials Science · doi:10.1039/d1bm01795k · Cited by 6
Identifying chronic alcoholism drug disulfiram as a potent DJ-1 inhibitor for cancer therapeutics
Wu, Q., Zhang, M., Wen, Y., He, P., He, Q., Yang, B., Li, J., Meng, Y. G., & Cao, J. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175035 · Cited by 6
Self-citationJin, R., Yang, Z., Sun, J., Chang, Q., Cai, L., & Lin, C. (2022) · Journal of Applied Polymer Science · doi:10.1002/app.53043 · Cited by 6
EK-DRD: A Comprehensive Database for Drug Repositioning Inspired by Experimental Knowledge
Zhao, C., Dai, X., Li, Y., Guo, Q., Zhang, J., Zhang, X., & Wang, L. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00365 · Cited by 6
Wang, S., Shen, Y., Hu, B., Wu, Q., Wang, N., Wang, Z., Zhang, Z.-F., Li, Y., & Jiang, J. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c11318 · Cited by 5
Drug Repurposing in Veterinary Oncology: Myth or Reality?
Ciccarelli, S., Perrone, C., Cavalera, M. A., & Giuliano, A. (2025) · Veterinary Sciences · doi:10.3390/vetsci12111067 · Cited by 5
Cuproptosis as a regulator in human diseases: From basic mechanisms to clinical relevance
Chen, X., Huang, L., Liu, R., Nan, D., Li, Y., Chen, W., Shi, L., Wang, Y., Liang, X., Tang, J., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115788 · Cited by 7
Nanocuproptosis for precision tumor immunotherapy
He, A., Li, Q., Zhang, Y., Dang, M., Li, X., Zheng, J., Xiu, W., Mou, Y., & Dong, H. (2025) · Nano TransMed · doi:10.1016/j.ntm.2025.100099 · Cited by 5
A deep learning and large language hybrid workflow for omics interpretation
Tang, D., Zhang, C., Zhang, W., Lu, F., Xiao, L., Huang, X., Shao, J., Liu, D., Fu, S., Zhao, M., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01576-5 · Cited by 5
Lv, H., Yang, H., Duan, Y., Sha, H., & Zhao, Z. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02906-7 · Cited by 5
Mechanisms associated with cuproptosis and implications for ovarian cancer
Chen, B., & Liu, J. (2024) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2024.112578 · Cited by 6
Vitamin A Metabolism and Resistance of Hepatic Metastases to Immunotherapy
Jones, P. C., & Hoff, D. D. V. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-0367 · Cited by 6
Han, J.-H., Ye, L., & Wang, Y. (2024) · Biomolecules · doi:10.3390/biom14111349 · Cited by 5
Nanoparticle-enabled In Situ drug potency activation for enhanced tumor-specific therapy
Chen, Y., Liu, L., Li, M., Chen, X., Li, Y., Tao, J., & Deng, Y. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106989 · Cited by 5
Sun, R., Huang, Y., Feng, H., Zhao, N., Wan, W., Shen, D., Zhong, B., Zhang, Y., Zhang, X., Zhao, Q., et al. (2025) · Advanced Science · doi:10.1002/advs.202413063 · Cited by 6
Rodríguez‐Acebes, S., Martín-Rufo, R., Gómez-Moya, A., Churcher, S. B., Fernández-Llorente, A., de la Vega-Barranco, G., Perona, A., Oroz, P., Martín‐Doncel, E., Toledo, L. I., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60077-w · Cited by 5
Raji, R. O., Balogun, S., Aliu, T. B., & Badmus, K. (2025) · BIOMED natural and applied science · doi:10.53858/bnas05020119 · Cited by 5
Jiang, H., Wei, J.-H., Lin, C., Liang, G.-B., He, R.-J., Huang, R.-Z., Ma, X., Huang, G., & Zhang, Y. (2022) · Metallomics · doi:10.1093/mtomcs/mfac072 · Cited by 5
Effect of Disulfiram on the Reproductive Capacity of Female Mice
Teng, M., Luo, Y., Wang, C., & Lei, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032371 · Cited by 5
Moon, O. J., Yoon, C. J., Lee, J. S., Kim, H. H., Seol, Y. H., & Lee, J. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.145176 · Cited by 5
An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
Yuan, X., & Wang, X. (2023) · Nanomaterials · doi:10.3390/nano13243144 · Cited by 5
Metadata
- Authors
- Skrott, Z., Mistrik, M., Andersen, K. K., Friis, S., Majera, D., Gursky, J., Ozdian, T., Bartkova, J., Turi, Z., Moudry, P., Kraus, M., Michalova, M., Vaclavkova, J., Dzubak, P., Vrobel, I., Pouckova, P., Sedlacek, J., Miklovicova, A., Kutt, A., Li, J., Mattova, J., Driessen, C., Dou, Q. P., Olsen, J., Hajduch, M., Cvek, B., Deshaies, R. J., & Bartek, J.
- Affiliations
- Danish Cancer Society (DK)
- Institute of Molecular and Translational Medicine (CZ)
- Kantonsspital St. Gallen (CH)
- Charles University (CZ)
- Nemocnice Šternberk (CZ)
- California Institute of Technology (US)
- Wayne State University (US)
- Palacký University Olomouc (CZ)
- Corresponding author
- Cvek, Boris
- Deshaies, Raymond J.
- ORCID
- Venue
- Nature
- Published
- 2017-12
- Volume
- 552
- Issue
- 7684
- Pages
- 194-199
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5730499
- OpenAlex
- W2772508026
- Cited by
- 807
- References
- 53
- Citations by year
- 2026: 76 · 2025: 108 · 2024: 120 · 2023: 108 · 2022: 112 · 2021: 81 · 2020: 92 · 2019: 60 · 2018: 50
- FWCI
- 22.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Lundbeckfonden (R93-2011-8990)
- National Cancer Institute (R01CA164803)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- disulfiram, drug repurposing, cancer, Npl4, VCP, diethyldithiocarbamate, cancer mortality, tumor suppression, protein turnover, stress response, biomarkers, cell death
- MeSH terms
- Adult, Alcohol Deterrents, Alcoholism, Animals, Antineoplastic Agents, Copper, Denmark, Disulfiram, Female, Humans, Male, Middle Aged, Neoplasms, Nuclear Proteins, Protein Binding, Heat-Shock Response, Mice, Drug Repositioning, Molecular Targeted Therapy, Proteolysis, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review